interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Tiotropium Bromide

Generic competition · all medicines · read 12 November 2026

Is there a generic of Tiotropium Bromide, and who makes it?

Tiotropium Bromide appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 1 generic maker listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 19.4 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Tiotropium Bromide2 dosage-form groups in the Orange Book
1generic maker listed
  1. Tiotropium Bromide appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 1 generic maker listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came 19.4 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Powder, Inhalation

One to three generic makers listed

Brand listed as marketed: Spiriva. 1 generic maker with 1 generic product listed as marketed; the first generic approval is dated 20 June 2023.

200020052010201520202025203001brand 2004Lupin Inc, first approval 20 June 2023data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Lupin Inc20 June 20231

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Spray, Metered, Inhalation

Brand listed, no generic listed as marketed

Brand listed as marketed: Spiriva Respimat. No generic is listed as marketed.

20102015202020252030203501brand 2014data datePatent 7396341*PED listed to expire 10 April 2027Patent 9027967*PED listed to expire 30 September 2027Patent 7837235*PED listed to expire 13 September 2028Patent 8733341*PED listed to expire 16 April 2031
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 10 April 2027Patent 7396341*PED
  • 30 September 2027Patent 9027967*PED
  • 13 September 2028Patent 7837235*PED
  • 16 April 2031Patent 8733341*PED

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.